Trinity Biotech Files 6-K for December 2024
Ticker: TRIB · Form: 6-K · Filed: Dec 27, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Dec 27, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2,306,000, $0.0109 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
Trinity Biotech filed a 6-K on 12/27/24, confirming foreign private issuer status and 20-F filings.
AI Summary
Trinity Biotech plc filed a Form 6-K on December 27, 2024, for the month of December 2024. The filing indicates that the company is a foreign private issuer and will file annual reports under Form 20-F. The principal executive office is located in Bray, County Wicklow, Ireland.
Why It Matters
This filing serves as a routine update for investors, confirming Trinity Biotech's status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- 20241227 (date) — Filing Date
- December 2024 (date) — Reporting Period
- Form 20-F (document) — Annual Report Filing
- Bray, County Wicklow, Ireland (location) — Principal Executive Office
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K is to report information for the month of December 2024, as required for a foreign private issuer.
What is Trinity Biotech's filing status regarding annual reports?
Trinity Biotech indicates it files annual reports under cover of Form 20-F.
Where is Trinity Biotech's principal executive office located?
Trinity Biotech's principal executive office is located at IDA Business Park, Bray, County Wicklow, Ireland.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is December 27, 2024.
Is Trinity Biotech submitting this Form 6-K in paper format?
The filing does not explicitly state that the Form 6-K is being submitted in paper format under Regulation S-T Rule 101(b)(1) or 101(b)(7); checkboxes for these options are not marked.
Filing Stats: 379 words · 2 min read · ~1 pages · Grade level 13.2 · Accepted 2024-12-27 16:14:05
Key Financial Figures
- $2,306,000 — he Company may sell up to an additional $2,306,000 of American Depositary Shares ("ADSs"),
- $0.0109 — Company's A Ordinary Shares, par value $0.0109 per share, from time to time, through C
Filing Documents
- zk2432495.htm (6-K) — 18KB
- exhibit_5-1.htm (EX-5.1) — 79KB
- image00001.jpg (GRAPHIC) — 17KB
- image00003.jpg (GRAPHIC) — 15KB
- image00004.jpg (GRAPHIC) — 89KB
- 0001178913-24-004058.txt ( ) — 264KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/Louise Tallon Louise Tallon Chief Financial Officer Date: December 27, 2024